0001376339false00013763392024-06-052024-06-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________

FORM 8-K
____________________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 5, 2024
MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
Florida001-3588726-2792552
(State or other jurisdiction(Commission(IRS Employer
of incorporation)File Number)Identification No.)

1775 West Oak Commons Ct., NE, Marietta GA 30062
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (770) 651-9100
____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange
on which registered
Common Stock, $0.001 par value per shareMDXGThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐












Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 5, 2024, the Company held its 2024 Annual Meeting of shareholders (the “2024 Annual Meeting”).

At the 2024 Annual Meeting, 119,158,874 shares of Company common stock (i.e., approximately 80.74% of votes entitled to be cast at the 2024 Annual Meeting) were represented in person or by proxy.

At the 2024 Annual Meeting, the shareholders: (1) re-elected M. Kathleen Behrens, Ph.D., Joseph H. Capper, James L. Bierman, William A. Hawkins, III, Cato T. Laurencin, M.D., K. Todd Newton, Tiffany Olson, Dorothy Puhy, and Martin P. Sutter; (2) approved an advisory resolution regarding executive compensation; and (3) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

Set forth below is information regarding the votes cast for each proposal:

Proposal 1: Election of Nine Directors.


ForAgainstAbstainBroker Non-votes
M. Kathleen Behrens, Ph.D.88,757,7403,261,0911,745,87325,394,170
Joseph H. Capper91,927,1851,477,638359,88125,394,170
James L. Bierman91,357,6561,982,026425,02225,394,170
William A. Hawkins, III91,585,0241,713,758465,92225,394,170
Dr. Cato T. Laurencin91,347,9141,951,781465,00925,394,170
K. Todd Newton91,286,6511,952,708525,34525,394,170
Tiffany Olson89,133,3534,247,603383,74825,394,170
Dorothy Puhy91,591,3581,790,486382,86025,394,170
Martin P. Sutter91,251,4442,047,937465,32325,394,170

Proposal 2: Advisory approval of executive compensation.

ForAgainstAbstainBroker Non-votes
Total Shares Voted68,695,86923,968,9151,099,92025,394,170


Proposal 3: Ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

ForAgainstAbstainBroker Non-votes
Total Shares Voted116,730,5202,328,64899,706N/A





SIGNATURES

Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MIMEDX GROUP, INC.
June 7, 2024By:/s/ William “Butch” Hulse
William “Butch” Hulse
General Counsel & Chief Administrative Officer

v3.24.1.1.u2
Cover Page Document
Jun. 05, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 05, 2024
Entity Registrant Name MIMEDX GROUP, INC.
Entity Incorporation, State or Country Code FL
Entity File Number 001-35887
Entity Tax Identification Number 26-2792552
Entity Address, Address Line One 1775 West Oak Commons Ct., NE
Entity Address, City or Town Marietta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30062
City Area Code 770
Local Phone Number 651-9100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol MDXG
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001376339
Amendment Flag false

MiMedx (NASDAQ:MDXG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse MiMedx
MiMedx (NASDAQ:MDXG)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse MiMedx